Article info
PDFNeurological rarities
‘Insulin neuritis’ to ‘treatment-induced neuropathy of diabetes’: new name, same mystery
- Correspondence to Dr Yun Tae Hwang, Department of Neurology, Royal Free Hospital, London NW3 2QG, UK; yun.hwang{at}nhs.net
Citation
‘Insulin neuritis’ to ‘treatment-induced neuropathy of diabetes’: new name, same mystery
Publication history
- Accepted August 31, 2015
- First published September 21, 2015.
Online issue publication
April 14, 2016
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://www.bmj.com/company/products-services/rights-and-licensing/
Other content recommended for you
- Treatment-induced diabetes neuropathy: description of singular clinical signs to reach a prompt diagnosis
- Treatment-induced diabetes neuropathy: reminder of an important clinical lesson
- Painful diabetic neuropathy
- Advances in diagnosis and management of distal sensory polyneuropathies
- Why do some people with type 2 diabetes who are using insulin have poor glycaemic control? A qualitative study
- Diagnosis and management of sensory polyneuropathy
- Effect of treatment with exenatide and pioglitazone or basal-bolus insulin on diabetic neuropathy: a substudy of the Qatar Study
- Characterizing the weight-glycemia phenotypes of type 1 diabetes in youth and young adulthood
- Intensified follow-up of patients with type 1 diabetes and poor glycaemic control: a multicentre quality improvement collaborative based on data from the Norwegian Diabetes Register for Adults
- Near-normoglycaemia and development of neuropathy: a 24-year prospective study from diagnosis of type 1 diabetes